Tilray Brands (TLRY) EBITDA Margin (2017 - 2026)
Tilray Brands (TLRY) posted EBITDA Margin of 12.76% for Q1 2026, down 24.61% on a QoQ basis from 10.24% in Q4 2025, and up 39629.0% year-over-year from N/an in Q1 2025.
Tilray Brands (TLRY) EBITDA Margin (2017 - 2026) Analysis & Trends
Tilray Brands' EBITDA Margin history runs 10 years deep, the most recent figure standing at 12.76% for Q1 2026.
- Quarterly EBITDA Margin rose 39629.0% year-over-year to 12.76% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 173.67% (down 7021.0% YoY) and the FY2025 annual result came in at 277.93%, down 25579.0% from the prior year.
- EBITDA Margin was 12.76% for Q1 2026 at Tilray Brands, down from 10.24% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1.0% in Q3 2025 and bottomed at 828.86% in Q1 2023.
- A 5-year average of 144.03% and a median of 20.01% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin tumbled 81696 bps — and 2024, when it surged 78527 bps.
- Tilray Brands' EBITDA Margin stood at 35.93% in 2022, then soared by 40 bps to 21.55% in 2023, then increased by 7 bps to 20.01% in 2024, then surged by 49 bps to 10.24% in 2025, then retreated by 25 bps to 12.76% in 2026.
- Business Quant data shows TLRY's EBITDA Margin at 12.76% in Q1 2026, 10.24% in Q4 2025, and 1.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | -12.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -12.76% |
| Nov 30, 2025 | -10.24% |
| Aug 31, 2025 | 1.00% |
| May 31, 2025 | -643.10% |
| Feb 28, 2025 | -409.05% |
| Nov 30, 2024 | -20.01% |
| Aug 31, 2024 | -18.28% |
| May 31, 2024 | -7.19% |
| Feb 29, 2024 | -43.59% |
| Nov 30, 2023 | -21.55% |
| Aug 31, 2023 | -19.42% |
| May 31, 2023 | -48.85% |
| Feb 28, 2023 | -828.86% |
| Nov 30, 2022 | -35.93% |
| Aug 31, 2022 | -13.82% |
| May 31, 2022 | -304.86% |
| Feb 28, 2022 | -11.90% |
| Nov 30, 2021 | -35.79% |
| Aug 31, 2021 | -41.29% |
| May 31, 2021 | -51.81% |